Opportunity
DIBBS #SPE2DP-26-Q-0113
DLA Solicitation for GlaxoSmithKline Meningococcal Group Vaccine (107 Units)
Posted
June 08, 2026
Respond By
June 11, 2026
Identifier
SPE2DP-26-Q-0113
NAICS
325414, 325412, 424210
This opportunity involves the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharmacy FSA seeking Meningococcal Group vaccines for military use. - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain Pharmacy FSA - Office: DLA Troop Support Medical Supply Chain Pharmacy FSA - OEMs and Vendors: - GlaxoSmithKline, LLC (OEM) - Products Requested: - Meningococcal Groups A, C, Y, and W-135 Oligosaccharide Diphtheria CRM Conjugate Vaccine for Injection - Part number: NDC58160-0955-09 (also referenced as NSN 6505-01-582-5875) - Quantity: 107 packages (5 doses per package) and 107 each (EA) - Shelf life: 24 months, non-extendable - Packaging: Must comply with Medical Marking Standard No. 1 and DLA packaging requirements - Delivery: FOB destination to USS Kearsarge LHD 3 - Unique/Notable Requirements: - Strict compliance with medical packaging and marking standards - 30-day delivery required after order - Shelf life requirement (24 months, non-extendable) - Federal Excise Tax line item included
Description
FEDERAL EXCISE TAX (QTY: Qty - See Solicitation, NSN: 0001S00000015, Purchase Request: 7017019987) MENINGOCOCCAL GROUP (QTY: 107, NSN: 6505-01-582-5875, Purchase Request: 7017019987) Approved Sources: - CAGE: 667E9, Part No: NDC58160-0955-09, Company: GLAXOSMITHKLINE, LLC